{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:35:44Z","timestamp":1782797744711,"version":"3.54.5"},"reference-count":27,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"\n Background & objectives:<\/jats:title>\n Drug resistance surveillance offers useful information on trends of drug resistance and the efficacy of control measures. Studies and reports of drug-resistant mutations and phenotypic assays thus become important. This study was conducted to investigate the molecular characteristics of ofloxacin (OFX)-resistant, multidrug-resistant tuberculosis (MDR-TB) isolates from different geographical regions of India and their association with strains of different genotypes. Further, the nitrate reductase assay (NRA) was tested against Mycobacteria Growth Indicator Tube (MGIT) for the determination of OFX resistance as an alternative and cost-effective method.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n A total of 116 Mycobacterium tuberculosis<\/jats:italic> isolates were used to assess the mutations in the gyrA<\/jats:italic>, gyrB<\/jats:italic> genes and resistance levels to OFX. Mutational analysis in gyrA<\/jats:italic> and gyrB<\/jats:italic> genes and genotype analysis of M. tuberculosis<\/jats:italic> isolates was done by gene-specific polymerase chain reaction (PCR) followed by DNA sequencing and spoligotyping, respectively.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Three (6.25%), 12 (44.44%) and 12 (29.27%) MDR-TB isolates from western, northern and southern India, respectively, were found to be OFX-resistant MDR-TB isolates. OFX resistance was observed to be significantly higher in MDR-TB cases for all study regions. Beijing genotypes from northern India were observed to be associated with OFX-resistant MDR-TB cases (P<\/jats:italic><0.05). Among 35 (30.15%) phenotypically OFX-resistant isolates, 22 (62.86%) had mutations in the gyrA<\/jats:italic> gene and two (5.71%) isolates had mutations in the gyrB<\/jats:italic> gene.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n These results caution against the PCR-based prediction of OFX resistance patterns and highlight the need for searching other genetic loci for the detection of mutations conferring resistance to OFX in M. tuberculosis<\/jats:italic>. Our study also showed the usefulness of NRA as an alternative method to detect OFX resistance.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_493_18","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T09:00:59Z","timestamp":1589274059000},"page":"361-370","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India"],"prefix":"10.25259","volume":"151","author":[{"given":"Anamika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Kumar","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"Uma Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shampa","family":"Anupurba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Nema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R2-15-20241212","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3201\/eid1309.070443","article-title":"Extensively drug-resistant Mycobacterium tuberculosis, India","volume":"13","author":"Mondal","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R3-15-20241212","doi-asserted-by":"crossref","first-page":"E55299","DOI":"10.1371\/journal.pone.0055299","article-title":"Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region","volume":"8","author":"Porwal","year":"2013","journal-title":"PLoS One"},{"key":"R4-15-20241212","first-page":"599","article-title":"Extensively drug-resistant tuberculosis in India: A review","volume":"136","author":"Michael","year":"2012","journal-title":"Indian J Med Res"},{"key":"R5-15-20241212","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4103\/0971-5916.182625","article-title":"A study on pre-XDR& XDR tuberculosis their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India","volume":"143","author":"Singhal","year":"2016","journal-title":"Indian J Med Res"},{"key":"R6-15-20241212","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1128\/JCM.00398-14","article-title":"Pseudo-outbreak of pre-extensively drug-resistant (Pre-XDR) tuberculosis in Kinshasa: Collateral damage caused by false detection of fluoroquinolone resistance by GenoType MTBDRsl","volume":"52","author":"Kaswa","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R7-15-20241212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF03256322","article-title":"Molecular diagnostics in tuberculosis: Basis and implications for therapy","volume":"13","author":"Balasingham","year":"2009","journal-title":"Mol Diagn Ther"},{"key":"R8-15-20241212","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3855\/jidc.1079","article-title":"Direct drug susceptibility testing of Mycobacterium tuberculosis against primary anti-TB drugs in northern India","volume":"4","author":"Gupta","year":"2010","journal-title":"J Infect Dev Ctries"},{"key":"R9-15-20241212","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3329\/jhpn.v29i1.7563","article-title":"Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of Mycobacterium tuberculosis in North India","volume":"29","author":"Gupta","year":"2011","journal-title":"J Health Popul Nutr"},{"key":"R10-15-20241212","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JCM.40.2.553-555.2002","article-title":"Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay","volume":"40","author":"Angeby","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R13-15-20241212","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/jac\/dkp096","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis: An assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance","volume":"63","author":"Devasia","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R14-15-20241212","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jac\/dkt353","article-title":"Prospective multicentre evaluation of the direct nitrate reductase assay for the rapid detection of extensively drug-resistant tuberculosis","volume":"69","author":"Martin","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R15-15-20241212","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/jcm.31.2.406-409.1993","article-title":"Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a standardized methodology","volume":"31","author":"van Embden","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R16-15-20241212","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1128\/JCM.37.8.2607-2618.1999","article-title":"Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: Interlaboratory study of discriminatory power and reproducibility","volume":"37","author":"Kremer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R17-15-20241212","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1099\/jmm.0.070219-0","article-title":"Predictive value of direct nitrate reductase assay and its clinical performance in the detection of multi- and extensively drug-resistant tuberculosis","volume":"63","author":"Imperiale","year":"2014","journal-title":"J Med Microbiol"},{"key":"R18-15-20241212","first-page":"285","article-title":"Evaluation of direct microplate nitrate reductase assay as a rapid method for the detection of multiple and extensively tuberculosis drug resistance","volume":"35","author":"Abilleira","year":"2015","journal-title":"Biomedica"},{"key":"R19-15-20241212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/ijmm.IJMM_16_266","article-title":"Detection of ofloxacin resistance by nitrate reductase assay Mycobacterium tuberculosis isolates from extrapulmonary tuberculosis","volume":"35","author":"Shrivastava","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"R20-15-20241212","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.diagmicrobio.2010.06.017","article-title":"Evaluation of nitrate reductase assay for rapid detection of resistance to second-line drugs in Mycobacterium tuberculosis in a tertiary care hospital","volume":"68","author":"Visalakshi","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R21-15-20241212","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R22-15-20241212","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ja.2014.95","article-title":"Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin","volume":"68","author":"Singh","year":"2015","journal-title":"J Antibiot (Tokyo"},{"key":"R23-15-20241212","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/AAC.00287-09","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB","volume":"53","author":"Von Groll","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-15-20241212","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1128\/AAC.48.8.3175-3178.2004","article-title":"Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis","volume":"48","author":"Pasca","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-15-20241212","first-page":"123","article-title":"Patterns of TB drug-resistance in a tertiary care facility in Pune, India","volume":"2","author":"Pradhan","year":"2013","journal-title":"Clin Microbial"},{"key":"R26-15-20241212","doi-asserted-by":"crossref","first-page":"e0117421","DOI":"10.1371\/journal.pone.0117421","article-title":"High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India","volume":"10","author":"Selvakumar","year":"2015","journal-title":"PLoS One"},{"key":"R27-15-20241212","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1038\/s41598-018-27299-z","article-title":"Association of gyrA and rrs gene mutations detected by MTBDRsl V1 on Mycobacterium tuberculosis strains of diverse genetic background from India","volume":"8","author":"Rufai","year":"2018","journal-title":"Sci Rep"},{"key":"R28-15-20241212","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/AAC.00541-09","article-title":"Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam","volume":"53","author":"Duong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-15-20241212","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1128\/AAC.01792-13","article-title":"Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China","volume":"58","author":"Zhao","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R30-15-20241212","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/AAC.01228-13","article-title":"Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China","volume":"58","author":"Zhang","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_493_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:03:08Z","timestamp":1751497388000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/genotype-analysis-of-ofloxacin-resistant-multidrug-resistant-mycobacterium-tuberculosis-isolates-in-a-multicentered-study-from-india\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_493_18","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}